We found evidence for a protective effect of FADS2 expression on male CRC risk in naïve T cells producing interferon-gamma (IFN) upon activation (TN IFN) five days post-activation (OR=0.89, CI=0.85 to 0.93). The gene discussed is IFNG; the disease is colorectal carcinoma.